Skip to content

Phase 1b trial reports promising outcomes with olverembatinib plus blinatumomab in relapsed or refractory CML or ALL
SOHO 2026 posters not to miss: MPN edition with Dr. Gabriela Hobbs
Young investigators define the SOHO difference
Dr. Jerald Radich highlights meaningful posters in CML at SOHO 2026
The state of SOHO: a year of growth and opportunity

Insider Reader Survey

Join SOHO

Insider Podcast
Society Updates/Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Acute Myeloid Leukemia

ASH 2025 Acute Myeloid Leukemia News

Prof. Charles Craddock, CBE, discusses paradigm trial, transplant advances at ASH 2025

by SOHO Insider Editors
February 17, 2026
0 Comments

Leukemia Acute Lymphoblastic Leukemia Acute Myeloid Leukemia News

Assay targeting KMT2A rearrangements in AML now available

by SOHO Insider Editors
February 16, 2026
0 Comments

SOHO Asia 2026 Acute Myeloid Leukemia Video Interviews

John DiPersio, MD, PhD, provides AML highlights from SOHO Asia

by Leah Sherwood
February 11, 2026
0 Comments

ASH 2025 Leukemia Acute Myeloid Leukemia Myelodysplastic Syndromes Video Interviews

Dr. Kelly Bolton on ivosidenib in IDH1-mutated CCUS

by Leah Sherwood
January 21, 2026
0 Comments

ASH 2025 Cellular Therapy Leukemia Acute Myeloid Leukemia

Dr. Gwen Nichols, of Blood Cancer United, talks financial toxicity in blood cancer care

by Leah Sherwood
January 9, 2026
0 Comments

ASH 2025 Cellular Therapy Acute Myeloid Leukemia Chronic Lymphocytic Leukemia Aggressive B-Cell Lymphomas

Dr. Avalos highlights ASH 2025 takeaways, the future of blood cancer

by Leah Sherwood
January 5, 2026
0 Comments

ASH 2025 Leukemia Acute Myeloid Leukemia

Dr. Gruenbaum, of Blood Cancer United, discusses menin inhibitors in AML

by SOHO Insider Editors
December 17, 2025
0 Comments

Leukemia Acute Lymphoblastic Leukemia Acute Myeloid Leukemia News

Phase 1 study of menin inhibitor terminated early due to lack of response, differentiation syndrome

by Kerri Fitzgerald
December 3, 2025
0 Comments

Leukemia Acute Myeloid Leukemia

Novel AML product candidate granted orphan drug designation by FDA

by Leah Sherwood
November 5, 2025
0 Comments

Leukemia Acute Myeloid Leukemia

FDA approves revumenib in relapsed or refractory NMP1-mutated AML

by Leah Sherwood
October 24, 2025
0 Comments

1
2
3
4
5
6